Australia markets closed

Adial Pharmaceuticals, Inc. (ADIL)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.6200+0.0950 (+3.76%)
At close: 04:00PM EST
2.5200 -0.10 (-3.82%)
After hours: 07:20PM EST
Full screen
Trade prices are not sourced from all markets
Previous close2.5250
Open2.5000
Bid2.5100 x 1000
Ask2.6500 x 1000
Day's range2.5000 - 2.6500
52-week range1.8500 - 5.0800
Volume162,598
Avg. volume223,950
Market cap54.88M
Beta (5Y monthly)0.51
PE ratio (TTM)N/A
EPS (TTM)-1.0040
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est10.67
  • Zacks

    Is Adial Pharmaceuticals, Inc. (ADIL) Outperforming Other Medical Stocks This Year?

    Here is how Adial Pharmaceuticals, Inc. (ADIL) and Albireo Pharma (ALBO) have performed compared to their sector so far this year.

  • GlobeNewswire

    Adial Pharmaceuticals to Present at the H.C. Wainwright BioConnect 2022 Conference

    CHARLOTTESVILLE, Va., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced that William Stilley, Chief Executive Officer of Adial, will be presenting at the H.C. Wainwright BioConnect 2022 Conference being held virtually January 10-13, 2022. Adial’s presentation will be available

  • GlobeNewswire

    Adial Pharmaceuticals Completes Private Placement of Common Stock at $4.00 Per Share

    CHARLOTTESVILLE, Va., Dec. 22, 2021 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced that it has received the balance of $720,000 due from the $800,000 private placement previously disclosed by the Company on November 10, 2021 (the “Offering”). The shares of common stock sold in the Offerin